Insights from Overviewing Selective International Guidelines for Pediatric Asthma

Area of Science:

• Pediatric Pulmonology
• Allergy and Immunology

Background:

• Asthma is a chronic inflammatory airway disease common in children, with varying international management guidelines.
• Lack of uniform national guidelines in many Asian cities necessitates a practical perspective on current recommendations.

Purpose of the Study:

• To provide a practical overview of current childhood asthma management recommendations.
• To update physicians on diagnosis, severity classification, treatment options, and asthma control strategies.

Main Methods:

• Systematic literature search using PubMed Clinical Queries with keywords 'Asthma,' 'Pediatric,' and 'Guidelines.'
• Filters included 'Clinical Prediction Guides,' 'Etiology,' 'Diagnosis,' 'Therapy,' 'Prognosis,' and 'Narrow' scope.
• Search conducted in November 2022.

Main Results:

• Diagnosis relies on clinical symptoms, bronchodilator/corticosteroid response, and spirometry.
• Asthma is classified by symptom frequency, lung function (PEFR, FEV1), and atopy, ranging from intermittent to severe persistent.
• Management involves trigger avoidance, inhaled corticosteroids, and potentially antileukotrienes or long-acting beta-agonists (LABA) for uncontrolled symptoms. Severe exacerbations require oral/intravenous corticosteroids and hospitalization.

Conclusions:

• Pediatric asthma diagnosis is clinical, supported by lab tests.
• Treatment strategies are tailored to asthma severity, from intermittent to persistent.
• Inhaled bronchodilators and corticosteroids are foundational for asthma management.